Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | CES1 | P23141 | 5/20 | 0.41 |
| ▸ | CES2 | O00748 | 4/20 | 0.41 |
| ▸ | TYMP | P19971 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | F2 | P00734 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | DAO | P14920 | 1/20 | 0.39 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 4/20 | 0.39 |
| ▸ | CDK5 | Q00535 | 2/20 | 0.39 |
| ▸ | CDK5R1 | Q15078 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | SRC | P12931 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3689389 | 1.00 | TSHR (0.47) | TSHRGAACYP2C19CES1CES2 | |
| SCHEMBL3689392 | 0.86 | TSHR (0.48) | TSHRGAACYP2C19CES1CES2 | |
| SCHEMBL3958996 | 0.86 | TSHR (0.48) | TSHRGAACYP2C19CES1CES2 | |
| SCHEMBL8007984 | 0.86 | TSHR (0.48) | TSHRGAACYP2C19CES1CES2 | |
| SCHEMBL2045474 | 0.85 | TSHR (0.44) | TSHRGAACYP2C19CES1CES2 | |
| SCHEMBL2045476 | 0.85 | TSHR (0.44) | TSHRGAACYP2C19CES1CES2 | |
| SCHEMBL7651351 | 0.84 | CES1 (0.48) | TSHRGAACYP2C19CES1CES2 | |
| SCHEMBL9900449 | 0.84 | CES2 (0.50) | TSHRGAACYP2C19CES1CES2 | |
| SCHEMBL7805644 | 0.84 | CES1 (0.48) | TSHRGAACYP2C19CES1CES2 | |
| SCHEMBL9900446 | 0.84 | CES2 (0.50) | TSHRGAACYP2C19CES1CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9320752-B2 | Pesticidal ear tag | Y-TEX CORPORATION (US) | 2016-04-26 | — | — | US | disclosed |
| US-20130273134-A1 | PESTICIDAL EAR TAG | Y-TEX CORPORATION | 2013-10-17 | — | — | US | disclosed |
| US-8425925-B2 | Pesticidal tag | Y-TEX CORPORATION (US) | 2013-04-23 | — | — | US | disclosed |
| EP-2173164-A1 | PESTICIDAL EAR TAG | Y-Tex Corporation (UA) | 2010-04-14 | — | — | EP | disclosed |
| WO-2009005513-A1 | PESTICIDAL EAR TAG | Y-TEX CORPORATION (US) | 2009-01-08 | — | — | WO | disclosed |
| US-20090004236-A1 | PESTICIDAL EAR TAG | Y-TEX CORPORATION | 2009-01-01 | — | — | US | disclosed |
| JP-2008143818-A | OXIME GROUP-CONTAINING MILBEMYCIN DERIVATIVE | SANKYO AGRO KK | 2008-06-26 | — | — | JP | disclosed |
| JP-2007246462-A | 3,4-DIHYDROXYMILBEMYCIN DERIVATIVE AND METHOD FOR PRODUCING THE SAME | SANKYO AGRO KK | 2007-09-27 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130273134-A1 | PESTICIDAL EAR TAG | ABAT, AADAC, BRDT | TSHR 1393/4885GAA 1805/4885CYP2C19 2322/4885 |
| US-20090004236-A1 | PESTICIDAL EAR TAG | TMPO, BRDT, AADAC | TSHR 760/4885GAA 2249/4885CYP2C19 2331/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.